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Abstract
HTLV-I-specific CD8
+ T cells have been characterized with high frequencies in peripheral blood and cerebrospinal fluid and
production of proinflammatory cytokines, which contribute to central nervous system inflammation in HTLV-I-associated
myelopathy/tropical spastic paraparesis (HAM/TSP). However, little is known about the differences in CD8
+ T cell activation
status between asymptomatic carrier (ACs) and patients with HAM/TSP. The expression of CD244, a signaling lymphocyte
activation molecule (SLAM) family receptor, was significantly higher on CD8
+ T cells in HTLV-I-infected patients, both ACs
and patients with HAM/TSP, than those on healthy normal donors (NDs). Blockade of CD244 inhibited degranulation and
IFN-c production in CD8
+ T cells of patients with HAM/TSP, suggesting that CD244 is associated with effector functions of
CD8
+ T cells in patients with HAM/TSP. Moreover, SLAM-associated protein (SAP) was overexpressed in patients with HAM/
TSP compared to ACs and NDs. SAP expression in Tax-specific CTLs was correlated in the HTLV-I proviral DNA loads and the
frequency of the cells in HTLV-I-infected patients. SAP knockdown by siRNA also inhibited IFN-c production in CD8
+ T cells
of patients with HAM/TSP. Thus, the CD244/SAP pathway was involved in the active regulation of CD8
+ T cells of patients
with HAM/TSP, and may play roles in promoting inflammatory neurological disease.
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Introduction
HTLV-I infects 20 million people worldwide [1]. While the
majority of infected individuals are asymptomatic carriers (ACs) of
the virus, 5–10% of infected people develop either adult T cell
leukemia/lymphoma (ATL) [2] or a chronic, progressive neuro-
logical disease termed HTLV-I-associated myelopathy/tropical
spastic paraparesis (HAM/TSP) [3,4]. HAM/TSP is character-
ized by infiltration of perivascular inflammatory cells in the spinal
cord including HTLV-I-specific CD8
+ T cells CTLs [5,6]. High
frequencies of these effector cells have been demonstrated in
peripheral blood with even higher frequencies in cerebrospinal
fluid (CSF) of patients with HAM/TSP. HTLV-I-specific CTLs
produce various factors including IFN-c and TNF-a that may
suppress viral replication and kill infected cells or promote
bystander activation and killing of nearby resident glial cells
[7–15]. These studies suggested that HTLV-specific CTLs might
be immunopathogenic in the inflammatory lesions of patients with
HAM/TSP.
Despite HTLV-I-specific CTL responses, HTLV-I proviral
loads are significantly elevated in HAM/TSP patients compared
to AC [16]. Increased expression particularly of the trans-
activating viral gene encoding HTLV-I Tax has been suggested
to play a role in HTLV-I disease progression [10,17]. HTLV-I
Tax induces the expression of a various cellular genes, including
IL-2 [18], the a-chain of the IL-2 receptor (IL-2Ra) [19], IL-15
[20], and IL-15Ra [21]. Increased expressions of these critical
immune mediators directly contributes to CD8
+ T cell activation
and the ex vivo T cell proliferation observed in patients with
HAM/TSP [22]. Although HTLV-I-specific CTL responses have
been demonstrated in ACs and patients with HAM/TSP [23,24],
high expression of IFN-c in CD8
+ T cells specifically in HAM/
TSP patients compared to ACs have been reported to be induced
by interaction with virus-infected CD4
+ T cells and CD8
+ T cells
[8,9,25]. Recently, CD8
+ T cells in patients with HAM/TSP, but
not in ACs, were demonstrated to spontaneously degranulate and
produce IFN-c. Importantly, this CTL degranulation was shown
to be mediated by HTLV-I infection of mononuclear phagocytes
(MPs) with the concomitant expression of IL-15 [24]. Thus, the
activation of HTLV-I-specific CTLs in HAM/TSP is associated
with both virus and cytokines, although the relative contribution of
each of these factors to the observed dysregulation of chronically
activated virus-specific CD8
+ T cells in patients with HAM/TSP
remains to be determined.
Effector functions of CD8
+ T cells are known to be regulated by
various cellular receptors and their downstream molecules. The
signaling lymphocyte activation molecule (SLAM) family of
receptors and their associated adaptors play a pivotal role in the
control of both innate and adaptive immunity [26]. Recent
evidences indicate that the family of receptors and their signaling
PLoS Pathogens | www.plospathogens.org 1 December 2009 | Volume 5 | Issue 12 | e1000682cascades are also involved in various inflammatory diseases, such
as rheumatoid arthritis and inflammatory bowl disease [27–29].
SLAM family receptors consist of six immunoglobulin-like
molecules named CD150 (SLAM), CD244 (2B4), CD229 (Ly-9),
NK-T-B antigen (NTB-A; Ly-108), CD84 and CD2-like receptor
activating cytotoxic T cells (CRACC) [26,30]. These receptors are
differentially expressed on various immune cell types. Most of
these receptors recognize self-ligands, but only CD244 is
implicated in heterotypic interactions with CD48. CD244 is
present on natural killer (NK) cells, cd T cells, activated CD8
+ T
cells, monocytes and basophils [31–37]. Importantly, the expres-
sion of CD244 on CD8
+ T cells was correlated with T cell
activation, CTL differentiation and exhaustion [31,34,35,38,39].
High CD244 expression on CD8
+ T cells has been shown in
patients with HIV-1 infection [40], acute infectious mononucleosis
[41] and myelodysplastic syndrome [42]. Its ligand, CD48, is a
glyco-phosphatidylinositol (GPI)-linked receptor broadly expressed
on immune cells. CD244/CD48 interactions between antigen-
specific CD8
+ T cells and their targets or among CD8
+ T cells
themselves can augment cytotoxicity of their specific targets, IFN-
c production, and proliferation [43,44]. These immune responses
are regulated by downstream signals, including the adaptor
molecule, SLAM-associated protein (SAP). SAP is a small SH2-
domain containing protein, expressed in T cells, NK cells, NKT
cells, and some B cells [45–47]. Following CD244/CD48
interaction, SAP binds with high affinity to the cytoplasmic tail
of CD244 and regulates the signal transduction by recruiting SRC
kinases [48]. Patients with X-linked lymphoproliferative syndrome
(XLP) with SAP deficiency are characterized by a decrease in
cytotoxic function of NK cells and EBV-specific CD8
+ T cells
[49], suggesting that SAP also has critical role in cytotoxic function
of these cells. Since it has been demonstrated that activated
HTLV-I specific CTL may play an important role in the
pathogenesis of HAM/TSP and that CD244 is a crucial regulator
of CTL function, we characterized the expression of CD244 on
CD8
+ T cells of HTLV-I-infected patients and examined their
functions in patients with HAM/TSP. Here for the first time we
demonstrate that CD244 was overexpressed on CD8
+ T cells of
HTLV-I-infected patients compared to healthy normal donors
(NDs), and that the upregulation of the adaptor protein, SAP, in
CD8
+ T cells distinguished patients with HAM/TSP from ACs.
Moreover, blocking of CD244 and knockdown of SAP by siRNA
resulted in inhibition of CD8
+ T cell function, degranulation and
IFN-c expression, of patients with HAM/TSP. These data suggest
that CD244/SAP pathway is involved in active regulation of
CTLs in patients with HAM/TSP.
Results
CD244 expression on CD8
+ T cells of patients with HAM/
TSP
To determine whether CD244 expression correlates with
activation of CD8
+ T cells in HTLV-I-infected patients, CD244
expression on CD8
+ T cells was examined by flow cytometry in
NDs, ACs and patients with HAM/TSP. A representative
histogram demonstrates that CD244 expression was higher on
CD8
+ T cells of HTLV-I-infected patients, both in an AC and a
patient with HAM/TSP, than those of a ND (Figure 1 A). In NDs,
group analysis demonstrated that 13–62% of CD8
+ T cells
expressed CD244 (n=14; Figure 1 B). This result was comparable
to previous results that reported approximately 30–50% of CD8
+
T cells were CD244 positive in healthy donors [33]. In contrast,
CD8
+ T cells of HTLV-I-infected patients, both ACs and patients
with HAM/TSP had significantly higher levels of CD244
expression; 35–90% and 45–98% respectively (Figure 1 B). There
was no significant difference in CD244 expression between ACs
and patients with HAM/TSP (P.0.05). Moreover, CD244 was
expressed on Tax11-19-specific and CMV pp65-specific CD8
+ T
cells of HLA-A*0201 patient with HAM/TSP (Figure 1 C). NK
cells of all subjects expressed CD244 (.95%), and did not show
any differences in CD244 expression between NDs and HTLV-I-
infected patients (data not shown). These results demonstrated that
CD8
+ T cells of HTLV-I-infected patients, including antigen-
specific CTLs, showed significantly high CD244 expression,
compared to NDs.
Inhibition of degranulation and IFN-c expression in CD8
+
T cell by blockade of CD244
As interactions of CD244 and its ligand, CD48, have been
reported to augment cytotoxicity, IFN-c production and prolifer-
ation of CD8
+ T cells in mouse [43,44], high expression of CD244
on CD8
+ T cells may also augment functional human CD8
+ T cell
responses. It has been established that in ex vivo cultures of HAM/
TSP PBMCs, CD8
+ T cells are in close contact with HTLV-I-
infected cells and rapidly function to kill these infected cells by
secretion of lytic granules and cytokines [9,12,24,25]. Therefore,
to confirm the involvement of CD244 in this cytolytic process, we
assessed CD8
+ T cells of patients with HAM/TSP for their
cytotoxic activity as defined by degranulation (CD107 expression)
and IFN-c expression by blocking CD244 or its ligand, CD48.
Figure 2 A shows a representative dot plot of CD107a and IFN-c
expressions in CD8
+ T cells of ND and patients with HAM/TSP
after culture of whole PBMCs for 24 hours. As previously reported
[24], CD8
+ T cells of patients with HAM/TSP expressed both
CD107a and IFN-c after culture for 24 hours, whereas CD8
+ T
cells of ND did not (Figure 2 A). When anti-CD244 or anti-CD48
was titrated and cultured in PBMCs of a patient with HAM/TSP,
both antibodies inhibited CD107a and IFN-c expression in CD8
+
T cells of a patient with HAM/TSP in a dose dependent manner
(Figure 2 B). Figure 2 C shows the inhibitory effects of anti-CD244
and anti-CD48 (1mg/ml) on degranulation and IFN-c expression
of CD8
+ T cells in patients with HAM/TSP (n=7). Anti-CD244
Author Summary
Human T-lymphotropic virus type I (HTLV-I) is a retrovirus
that persistently infects 20 million people worldwide. The
majority of infected individuals are asymptomatic carriers
of the virus, but 5–10% of infected people develop either
adult T cell leukemia/lymphoma (ATL) or a chronic,
progressive neurological disease termed HTLV-I-associated
myelopathy/tropical spastic paraparesis (HAM/TSP). HAM/
TSP is characterized by central nervous system (CNS)
inflammation including HTLV-I-specific CD8
+ T cells where
disease progression and pathogenesis is associated with a
dysregulation of antigen-specific CD8
+ T cells, although
the mechanism of this dysregulation remains to be
defined. Here we demonstrate that a signaling lymphocyte
activation molecule (SLAM) family of receptors, CD244, was
overexpressed on CD8
+ T cells of HTLV-I-infected patients
than those of healthy normal donors, and that the
upregulation of the adaptor protein, SAP, in CD8
+ T cells
distinguished HTLV-I infected individuals with and without
neurologic disease. Both CD244 and SAP were associated
with effector functions (high expression of IFN-c) of CD8
+ T
cells in patients with HAM/TSP. This finding has important
implication for T cell-mediated pathogenesis in human
chronic viral infection associated with imbalance of
immune function.
CD244 and SAP Expression in HAM/TSP
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in CD8
+ T cells of patients with HAM/TSP compared with a
control isotype IgG. Anti-CD48 had an even more pronounced
inhibitory effect (65.5%). An additional established measure of
HAM/TSP T cell activation ex vivo is the well-described
observations of increased spontaneous T cell lymphoproliferation
[50]. However, blockade of CD244 did not show any inhibitory
effects on spontaneous lymphocyte proliferation of patients with
HAM/TSP (data not shown). These results demonstrate that
CD244/CD48 interactions might be specifically involved in
cytotoxic CD8
+ T cells dysregulation, especially degranulation
and IFN-c expression, of patients with HAM/TSP.
Although CD48 is broadly expressed on hematopoietic cells
including lymphocytes and monocytes, viral infection such as HIV
or EBV has been shown to decrease or increase CD48 expression
on the infected cell, respectively [51,52]. Therefore, we examined
Figure 1. Expression of CD244 on CD8
+ T cells of HTLV-I-infected patients. (A) Representative histograms of CD244 expression on CD8
+ T
cells of a ND, an AC and a patient with HAM/TSP. Staining in ND (opened histogram), AC (grayed histogram) and patient with HAM/TSP (closed
histogram) were shown. (B) Comparison of CD244 expression in CD8
+ T cells of NDs and HTLV-I-infected patients. The data were obtained from 14
NDs, 8 ACs and 13 patients with HAM/TSP. The horizontal line represents the median. (C) CD244 expression on antigen-specific CTLs. CD244
expressions were shown in Tax11-19- specific and CMVpp65-specific CD8
+ T cells of a patient with HAM/TSP.
doi:10.1371/journal.ppat.1000682.g001
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+ T cell degranulation and IFN-c expression of patients with HAM/TSP. (A) Representative dot
plot of spontaneous degranulation and IFN-c expression in CD8
+ T cells of a ND and a patient with HAM/TSP after culture for 24 hours. The PBMCs
were cultured for 24 hours without any exogenous stimulators. (B) Dose-dependent inhibition of spontaneous degranulation and IFN-c expression in
CD8
+ T cells of a patient with HAM/TSP by anti-CD244 (closed circle) and anti-CD48 (opened circle). The PBMCs were cultured with each antibody for
24 hours. (C) Inhibitory effects of anti-CD244 and anti-CD48 on degranulation and IFN-c production in CD8
+ T cells of patients with HAM/TSP. The
PBMCs were cultured with 1 mg/ml of control IgG, anti-CD244 or anti-CD48 for 24 hours. The amount of CD107a/IFN-c expressions of CD8
+ T cells
cultured with control IgG were normalized to 100%, and then, those in PBMCs cultured with each antibody were calculated. The graph was prepared
from data obtained from 7 patients with HAM/TSP. Error bars represent SD. (D) CD48 and Tax expression in HTLV-I-infected cells of a patient with
HAM/TSP. The top panels show CD48 and Tax expression in CD4
+ T cells before (left) and after (right) the culture for 20 hours. The bottom panels
show CD48 and Tax expression in CD14
+ cells before (left) and after (right) the culture for 20 hours.
doi:10.1371/journal.ppat.1000682.g002
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+ T cells and CD14
+ cells, which are
known to be in vivo reservoirs for HTLV-I in patients with HAM/
TSP and gradually express HTLV-I Tax protein after short term
in vitro culture [24,53]. Figure 2 D shows a representative result of
CD48 and HTLV-I Tax expression in CD4
+ T cells and CD14
+
cells of a patient with HAM/TSP. Both CD4
+ T cells and CD14
+
cells expressed CD48 before culture (Figure 2 B). CD48 expression
on CD4
+ T cells did not change over time despite the expression of
HTLV-I Tax (Figure 2 B). This result supports previous studies
that in vitro infection of HTLV-I in CD4
+ T cells did not alter
CD48 expression [54]. However, CD48 expression was partially
downregulated in CD14
+ cells after culture, but did not appear to
be directly mediated by HTLV-I Tax expression, because Tax was
not detected on the cells expressing low level of CD48 (Figure 2 B).
Collectively, these results demonstrate that HTLV-I expression
does not directly mediate CD48 expression on infected cells,
suggesting that CD244-expressing HTLV-I-specific CTLs have
the potential to interact with virus-infected CD48
+ target cells.
Distribution of CD244 during cell-cell interaction
It is well known that interactions between effector CD8
+ T cells
and their targets establish a distinct immunological synapse
organized by the accumulation of various immunoreceptors to
cell-cell junctions associated with the polarization of lytic granules,
such as perforin, leading to induction of cell death [55]. To
support further the involvement of CD244/CD48 signaling on
CD8
+ T cells in HTLV-I-infected patients, the distribution of
CD244 was visualized on cytotoxic lymphocytes (perforin
+ cells) of
patients with HAM/TSP after 8 hours in vitro culture when both
perforin
+ cells and polarizing perforin
+ cells were most frequently
visualized. As shown in Figure 3, immunofluorescence analysis
demonstrated colocalization of CD244 on perforin
+ cells (Figure 3
A and B). When these perforin
+ cells were in contact with their
targets, either strongly positive (Figure 3 A) or weakly positive
(Figure 3 B) for CD48, polarization of perforin with the
accumulation of CD244 was visualized at the cell-cell contact
area (Figure 3 A and B, middle). The accumulation of CD244 on
polarizing perforin
+ cells was observed in more than 30% of all the
polarizing perforin
+ cells in contact with another cell. These results
demonstrate that expression and subcellular distribution of CD244
and perforin on cytotoxic lymphocytes from HAM/TSP patients
was translocated to the contact area (immunological synapse) with
CD48
+ target cells, suggesting that CD244 on cytotoxic lympho-
cytes is involved in recognition of target cells or activation of
cytotoxic lymphocytes in HTLV-I-infected patients.
SAP expression in CD8
+ T cells of patients with HAM/TSP
Given the involvement of CD244/CD48 interaction on CD8
+
T cells of patients with HAM/TSP, we asked how CD244/CD48
signaling might regulate CD8
+ T cell function since high
Figure 3. Distribution of CD244 in PBMCs of patients with HAM/TSP. After the culture for 8 hours, PBMCs were stained with antibodies
against perforin, CD244 and CD48, and visualized through microscope. Two representative 3D images were shown in A and B. The image shows DAPI
(blue), perforin (green), CD244 (orange) and CD48 (purple). In addition to DAPI and perforin (left), CD244 (middle) and CD48 (right) are merged. The
white arrows indicate CD244 clustering at the cell contact area.
doi:10.1371/journal.ppat.1000682.g003
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+ T cells of both
ACs and patients with HAM/TSP. It is known that NK cells
constitutively express CD244 [33]. However, the regulation of
these cells, either in a resting or activated state, is related to the
expression of the SLAM-related adaptor proteins such as SAP and
EAT-2, which play a role in controlling the active and inhibitory
signal transduction in NK cells, respectively [32,56–58]. To
determine whether SLAM-related adaptor proteins were associ-
ated with active regulation of CD8
+ T cells, the expression of the
adaptor proteins, SAP and EAT-2, were compared in CD8
+ T
cells of NDs, ACs and patients with HAM/TSP. Representative
results of SAP expression in CD8
+ T cells are shown in Figure 4.
SAP expression was higher in CD8
+ T cells of a patient with
HAM/TSP compared to that of ND and AC (Figure 4 A). Group
analysis demonstrates that compared with the expression of SAP
on CD8
+ T cells of NDs and ACs, SAP expression was
significantly increased in CD8
+ T cells of patients with HAM/
TSP (Figure 4 B). Although CD8
+ T cells of ACs expressed SAP
slightly higher than those of NDs, statistical analysis did not show
any significant differences between these groups. The expression of
SAP in NK cells were 43.9%, 44.6%, and 58.0% on average in
NDs, ACs, and patients with HAM/TSP, respectively, and was
not significantly different among groups. Likewise, EAT-2 was
highly expressed in CD8
+ T cells of both NDs and HTLV-I-
infected individuals with no significant differences observed
(Figure 4 C). These results demonstrate that CD8
+ T cells of
patients with HAM/TSP overexpress SAP compared to NDs and
ACs, although EAT-2 expression was comparable in all three
groups.
To assess SAP expression in antigen-specific CTL, we examined
HTLV-I Tax11-19 tetramer
+ CD8
+ T cells in HLA-A*0201
+ AC
and patient with HAM/TSP. As shown in a representative
histogram, SAP expression was higher in Tax tetramer
+ CD8
+ T
cells of patient with HAM/TSP than the AC (Figure 4 D). To
address SAP expression in these antigen-specific CD8
+ T cells, we
analyzed the HTLV-I proviral DNA loads in PBMCs and the
frequency of Tax11-19 tetramer
+ CD8
+ T cells in HTLV-I-
infected individuals as a function of SAP expression. As previously
reported [9,12], patients with HAM/TSP had higher frequencies
of Tax11-19 tetramer
+ CD8
+ T cells, compared to ACs that
correlated with HTLV-I proviral DNA loads. Figure 4E demon-
strates that the amount of SAP expression in Tax11-19 tetramer
+
CD8
+ T cells was significantly correlated with HTLV-I proviral
DNA loads in PBMCs (P=0.0401, R
2=0.4746) and the
frequency of Tax11-19 tetramer
+ CD8
+ T cells in HTLV-I-
infected individuals (P=0.0062, R
2=0.6811). These results
suggest that expansion of HTLV-I-specific CD8
+ T cells
particularly in patients with HAM/TSP is associated with the
expression of SAP and can distinguish patients with neurologic
disease from HTLV-I infected asymptomatic carriers.
Increase of SAP expression in IL-2- and IL-15-stimulated
CD8
+ T cells
HTLV-I Tax induces the expression of a various cytokine genes,
including IL-2 and IL-15, which has been shown to be associated
with CD8
+ T cell activation and proliferation in patients with
HAM/TSP [22]. IL-15 plays an important role in the prolonged
maintenance of memory CD8
+ T cell responses [59]. To examine
whether IL-2 and IL-15 can upregulate SAP and CD244
expression in CD8
+ T cells, purified CD8
+ T cells from ND
PBMCs (n=2) were cultured with recombinant human IL-2
(rhIL-2) or rhIL-15 for 7 days, and expression of SAP and CD244
in these cells were analyzed. Both rhIL-2 and rhIL-15 stimulation
induced SAP expression in CD8
+ T cells of NDs, depending on the
concentration of rhIL-2 or rhIL-15 (Figure 5 A). In addition, the
magnitude of SAP expression in CD8
+ T cells by IL-2 and IL-15
was variable among individuals. By contrast, CD244 expression on
CD8
+ T cells did not change after culture with rhIL-2 and rhIL-15
(Figure 5 B). Thus, IL-2 or IL-15 stimulated CD8
+ T cells showed
high expression of SAP, suggesting that the observed upregulation
of SAP in CD8
+ T cells of patients with HAM/TSP may be a
function of increased cytokine production.
Inhibition of degranulation and IFN-c expression in CD8
+
T cells by SAP knockdown
Upregulation of SAP may be related to dysregulation of
chronically activated CD8
+ T cells in patients with HAM/TSP.
To confirm the involvement of SAP on dysregulation of CD8
+ T
cells in patients with HAM/TSP, we examined degranulation and
IFN-c expression in CD8
+ T cells of patients with HAM/TSP after
knockdown of SAP or EAT-2 by siRNA. SAP and EAT-2
expression in transfected CD8
+ T cells was determined after culture
for 6 hours. Gene knockdowns by siRNA were effective against
their respective targets at levels of 50–60% of baseline (Figure 6 A).
After coculture with autologous CD14
+ cells, CD8
+ T cells
transfected with SAP siRNA significantly decreased degranulation
and IFN-c expression (40.5% inhibition, P=0.005) compared to
CD8
+ T cells transfected with control siRNA (Figure 6 B) while
CD8
+ T cells transfected with EAT-2 siRNA had no inhibitory
effect. The inhibitory effect of SAP siRNA was similar to those of
anti-CD244 on degranulation and IFN-c expression in CD8
+ T
cells of patients with HAM/TSP (Figure 2 C). These results
demonstrate that decreased SAP expression resulted in inhibition of
degranulation and IFN-c expression in CD8
+ T cells of patients
with HAM/TSP, supporting the role for SAP in the activation of
cytotoxic CD8
+ T cell function in patients with HAM/TSP.
Discussion
Activation and dysregulation of CD8
+ T cells in HTLV-I-
infected patients have been suggested to be associated with disease
progression and pathogenesis of HAM/TSP [7–15]. In this study,
we have characterized that a member of the SLAM family of
receptors, CD244, was overexpressed on CD8
+ T cells of HTLV-
I-infected patients compared to NDs, and demonstrated that the
upregulation of the adaptor protein, SAP, in CD8
+ T cells
distinguished patients with HAM/TSP from ACs. The expression
of CD244 on CD8
+ T cells correlated with T cell activation
[31,34,35,38], as has been reported in patients with HIV-1
infection [40], acute infectious mononucleosis [41], and myelo-
dysplastic syndrome [42]. CD244
+ CD8
+ T cells lack expression of
CD45RA, CD62L, CD28, and CCR7 and acquire expression of
perforin, granzyme B, and IFN-c [31,35,38]. In addition, 2B4
+
cells (also known as CD244) showed higher cytotoxicity than 2B4
2
T cells [31,34]. Since high frequency of CD45RA
2CD27
+
memory CD8
+ T cells and high proliferation rate of CD8
+
CD45RO
+ T cells have been reported in patients with HAM/TSP
[10,60] and in HTLV-I-infected patients (both ACs and patients
with HAM/TSP [61]), the expression of CD244 on CD8
+ T cells
in HTLV-I-infected patients is consistent with the interpretation
that CD244 is a marker of memory CD8
+ T cells and with
persistent immune activation in HTLV-I-infected patients. High
CD244 expression was demonstrated on HTLV-I Tax11-19-
specific CD8
+ T cells as well as CMV pp65-specific CD8
+ T cells
in a patient with HAM/TSP. Previous results have shown that
CMV pp65-specific CD8
+ T cells also showed high expression of
CD244 whereas influenza virus-specific and melanoma antigen-
specific CD8
+ T cells showed low or negative expression of
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+ T cells of HTLV-I-infected patients. (A) Representative histograms of SAP
expression in CD8
+ T cells of a ND (opened histogram), an AC (grayed histogram), and a patient with HAM/TSP (closed histogram). (B) Comparison of
SAP expression in CD8
+ T cells of NDs (n=11), ACs (n=8) and patients with HAM/TSP (n=10). The horizontal line represents the median. (C)
Comparison of EAT-2 expression in CD8
+ T cells of NDs (n=10), ACs (n=5) and patients with HAM/TSP (n=10). (D) SAP expression in Tax11-19-
specific CTLs of HTLV-I-infected patients. SAP expressions were shown in Tax11-19-specific CD8
+ T cells of AC and patient with HAM/TSP. (E)
Correlation of the HTLV-I-proviral DNA loads (circles; R
2=0.4746, P=0.0401) and the frequency of Tax11-19-specific CD8
+ T cells (squares R
2=0.6811,
P=0.0062) with SAP expression in the cells of AC (n=4, opened circles and squares) and patients with HAM/TSP (n=5, closed circles and squares).
doi:10.1371/journal.ppat.1000682.g004
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has been recently reported to be related to CD8
+ T cell exhaustion
during chronic LCMV infection in mouse [39]. In our study, there
were no differences in CD244 expression on CD8
+ T cells between
ACs and patients with HAM/TSP (Figure 1 B) and expression of
CD244 in HTLV-I-infected patients did not show any direct
correlation with HTLV-I infection such as HTLV-I proviral load
or expression of Tax (data not shown). Thus, expression of CD244
on CD8
+ T cells might indicate the activation state of CD8
+ T
cells or degree of CTL differentiation in chronic viral infection.
As suggested by the analyses of the disorder XLP, which is
characterized by SAP deficiency and a decrease in cytotoxic
function of NK cells and EBV-specific CD8
+ T cells, the apparent
activating effect of CD244 in human NK cells and CD8
+ T cells
mayrelatetopreferentialexpressionofSAP[32,56,62–64].Herewe
have demonstrated a disease-specific upregulation of the adaptor
protein,SAP,inCD8
+TcellsofpatientswithHAM/TSP but notin
NDsorACs.ThisobservationwasspecificforSAPsinceEAT-2was
comparably expressed in both NDs, and HTLV-I-infected patients
and carriers. Moreover, the expression of SAP was higher in both
totalCD8
+T cellsand inTax11-19-specific CD8
+T cellsinpatients
with HAM/TSP compared to ACs. Interestingly, while expression
ofCD244inHTLV-I-infectedpatientsdidnot show anycorrelation
with HTLV-I infection, the upregulation of SAP in Tax11-19-
specific CD8
+ T cells was significantly correlated with the HTLV-I
proviral DNA load in PBMCs and the frequency of Tax11-19-
specific CD8
+ T cells in HTLV-I-infected patients, suggesting that
the expression of SAP is associated with the increase of proviral
DNA and the expansion of antigen-specific CD8
+ T cells. This is
consistent with previous reports that demonstrated the relationship
of disease progression with proviral DNA loads and virus-specific
CD8
+ T cells [17]. Upregulation of SAPwas reported in splenocytes
of mice infected with LCMV and MCMV [56], and in PBMCs of
patients with infectious mononucleosis, even during early stages of
the disease [41]. While SAP expression in NK cells is related to
stimulation with NK cell activators, such as IL-2, IL-12, IFN-a and
poly(I:C) [56,58], regulation of SAP expression in human CD8
+ T
cell is still unclear [64–66]. Since the expansion of HTLV-I-specific
CD8
+ T cells in HTLV-I infected patients is known to be influenced
by various cytokines such as IL-2 and IL-15 as well as by virus
antigen, we reasoned that these same stimuli would induce the
expression of SAP that we have shown to be elevated in HTLV-I
Figure 5. SAP and CD244 expressions in CD8
+ T cells of NDs after stimulation with IL-2 or IL-15. (A) SAP expressions in CD8
+ T cells
isolated from ND PBMCs were compared after the culture with rhIL-2 (opened circle) or rhIL-15 (closed circle) for 7 days. The graphs were prepared
from data obtained from two NDs (left and right). (B) CD244 expressions in CD8
+ T cells isolated from ND PBMCs were compared after the culture
with rhIL-2 (opened circle) or rhIL-15 (closed circle) for 7 days. The graphs were prepared from data obtained from two NDs (left and right).
doi:10.1371/journal.ppat.1000682.g005
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+ T cells.In our study,stimulation ofNDsCD8
+ T cells
with IL-2 and IL-15 induced SAP but not CD244 expression on
CD8
+ T cells. Indeed, while TCR activation was strongly correlated
with expression of CD244 on CD8
+ T cells, as previously reported
[64], stimulation of cytokines such as IL-2 and IL-15 induced
upregulationofSAPinCD8
+Tcells.Therefore,comparedtoCD8
+
T cells in ACs with high expression of CD244 and low expression of
SAP,high expression ofCD244andSAPinCD8
+T cellsofpatients
with HAM/TSP may be regulated by these cytokine-dependent
activation as well as TCR dependent activation.
Results presented in this study also demonstrate that CD244/
SAP pathway was functionally involved in cytotoxic activity of
CD8
+ T cells in patients with HAM/TSP. Immunofluorescence
analysis visualized CD244
+ perforin
+ cytotoxic T cells in contact
with CD48
+ cells where clusters of CD244 and perforin were
localized to the cell-cell contact area. These results demonstrated
that CD244 on cytotoxic lymphocytes is involved in recognition of
target cells or activation of cytotoxic lymphocytes. Recruitment of
lytic molecules such as perforin to the cell-cell contact area
suggests induction of target cell death. Moreover, analysis of CD8
+
T cell function in patients with HAM/TSP as defined by
degranulation and IFN-c expression was inhibited by blockade
of CD244 or knockdown of SAP, but not EAT-2. However, since
spontaneous degranulation and IFN-c expression was not detected
in CD8
+ T cells of ACs [24], we suggest that high expression of
CD244 alone was not directly responsible for spontaneous
degranulation and IFN-c expression of CD8
+ T cells. Rather,
the overexpression of SAP in CD8
+ T cells of patients with HAM/
TSP, with high expression of CD244, might contribute to the CTL
activity observed in this disorder by overproduction of IFN-c and
other inflammatory mediators. These results confirmed that
expression of both CD244 and SAP are associated with CD8
+ T
cell activity, as previously reported [64]. The CD244/SAP
pathway has been shown to regulate effector functions of NK
and T cells depending on the expression level of CD244 and SAP
[67]. Our results extends the significance of the CD244/SAP
pathway in activation and regulation of virus-specific CD8
+ T cell
responses and has important implications for T cell-mediated
pathogenesis of inflammatory neurologic disorders associated with
an imbalance of immune function.
Materials and Methods
Patient samples
Blood samples were obtained from thirteen patients with
HAM/TSP (HAM#1-13), eight AC (AC#1-8) and fourteen
HTLV-I-seronegative healthy donors (ND#1-14). Diagnosis of
HAM/TSP was based on World Health Organization (WHO)
diagnostic criteria. Five patients with HAM/TSP and four AC
were HLA typed as HLA-A*0201
+. PBMCs were isolated by
Ficoll-Hypaque (Lonza Walkersville, Walkersville, MD) centrifu-
gation, and were cryopreserved in liquid nitrogen until use.
Informed consent was written and obtained from each subject in
accordance with the Declaration of Helsinki. The study was
reviewed and approved by the National Institute of Neurological
Disorders and Stroke Institutional Review Board.
Antibodies and reagents
For flow cytometory, antibodies for human CD3, CD4, CD8,
CD14, CD48, CD107a, CD244, IFN-c, perforin (all from BD
Biosciences, San Jose, CA), SAP (Cell Signaling, Danvers, MA),
EAT-2 (Santa Cruz Biotechnology, Santa Cruz, CA), Tax 11–19/
HLA-A0201tetramer(providedbyNational InstituteofAllergyand
Infectious Disease MHC Tetramer Core Facility, Atlanta, GA) and
CMV pp65/HLA-A0201 tetramer (Beckman Coulter, San Diego,
CA) were used. Anti-Tax monoclonal antibody (Lt-4) was kindly
provided by Dr. Y. Tanaka (University of the Ryukyus, Okinawa,
Japan). For blocking experiments, both anti-CD244 and anti-CD48
were purchased from eBioscience (San Diego, CA). For immuno-
fluorescence microscopy, primary antibodies used were anti-CD244
(R&D systems; Minneapolis, MN), anti-CD48 (AbD Serotec;
Oxford, UK) and anti-perforin (BD Biosciences); and secondary
antibodies used were Alexa 546 donkey anti-goat IgG (H&L), Alexa
647goatanti-mouseIgG1,andAlexa488goatanti-mouseIgG2b(all
from Invitrogen; Carlsbad, CA), respectively. siRNAs specific for
SAP mRNA, EAT-2 mRNA and control siRNA were purchased
from Santa Cruz Biotechnology.Recombinanthuman(rh) IL-2and
rhIL-15 were purchased from Peprotech. (Rocky Hill, NJ).
CD107a mobilization assay
CD107a mobilization assay was performed as previously
described [24]. Briefly, PBMCs of ND or HTLV-I-infected patients
weresuspended inRPMI 1640mediasupplemented with 10%FBS,
Figure 6. Inhibition of degranulation and IFN-c expression in
CD8
+ T cells of patients with HAM/TSP by SAP siRNA. (A) SAP
and EAT-2 expression in transfected CD8
+ T cells with either control,
SAP or EAT-2 siRNA was determined after the culture for 6 hours. The
cell lysates were prepared from transfected CD8
+ T cells, and each 10mg
of the cell lysates was loaded on the gel. (B) Inhibitory effects of SAP or
EAT-2 siRNA on degranulation and IFN-c expression in transfected CD8
+
T cells. Isolated CD8
+ T cells from patients with HAM/TSP were
transfected with control, SAP or EAT-2 siRNA, and then cocultured with
autologous CD14
+ cells. The amounts of CD107a/IFN-c expressions in
CD8
+ T cells transfected with control siRNA were normalized to 100%,
and then, those in CD8
+ T cells transfected with SAP or EAT-2 siRNA
were calculated. The graph was prepared from data obtained from
three patients with HAM/TSP. Error bars represent SD.
doi:10.1371/journal.ppat.1000682.g006
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L-glutamine, and cultured in 24 well plate in 5% CO2 incubator at
37uC for 24 hours. In blocking experiments, 0, 0.1, 1 or 10 mg/mL
of each antibody (control IgG, anti-CD244 and anti-CD48) was
added. Conjugated CD107a antibody, GoldiStop
TM (BD Biosci-
ences), and brefeldin A (Sigma, St. Louis, MO) were added into the
culture for 5 hours before the time point for detection.
Immunofluorescent staining and flow cytometry
Expressions of CD107a, IFN-c, CD244, Tax, SAP or EAT-2 in
the cultured or uncultured PBMCs were examined by flow
cytometoric analysis. PBMCs were surface-stained with specific
antibodies. In the case of combination staining with tetrameric
complexes, PBMCs were stained with either Tax11-19 or CMV
pp65-specific tetramer before surface staining. After being fixed
and permeabilized with Fixation/Permeabilization solution (BD
Biosciences), the cells were intracellular-stained with antibodies
against IFN-c, Tax, SAP or EAT-2 for each experiment. Flow
cytometric analysis was performed using a FACSCalibur flow
cytometer (BD Biosciences). The data were analyzed using FlowJo
software (Tree Star, San Carlos, CA). To examine CD244 and
SAP expression in CD8
+ T cells stimulated with IL-2 or IL-15,
CD8
+ T cells were magnetically isolated from ND PBMCs by
negative selection using CD8
+ T cell isolation kit II (Miltenyi,
Bergisch Gladbach, Germany) and cultured with appropriate
concentration of rhIL-2 or rhIL-15 for 7 days.
Immunofluorescence microscopy
Lab tech chamber glass slides (Nalge Nunc International,
Rochester, NY) were coated with poly-L-lysine (Sigma) before use.
PBMCs were plated into the chamber slides with RPMI media,
and cultured for 8 hours. After washing with PBS including 1%
FBS, the cells were stained with primary antibodies for CD244
and CD48 for 1 hour at room temperature. After fixation with 4%
paraformardehide for 15 min and subsequent washing with PBS
including 0.1% Triton-X, cells were stained with a primary
antibody for perforin for 1 hour. After washing, each secondary
antibody was applied, and DAPI was finally used for nuclear
counterstaining. The stained cells were visualized with Zeiss 200M
Axiovert inverted microscope equipped with mercury lamp house
HBO-100 and four appropriate dichroic filters for DAPI and
Alexa 488, 546 and 647 (Carl Zeiss MicroImaging Inc, Thorn-
wood, NY). To evaluate the cell-cell contact and the distribution of
perforin, CD244 and CD48, polarizing perforin
+ cell and its
contacting cell was first identified under the microscope and then
the image picture was created using four filters for DAPI, perforin,
CD244 and CD48. Three-dimensional (3-D) reconstructions of
each section were assembled using Volocity 3-D imaging analysis
software (Improvision, Waltham, MA). The image data was
deconvoluted and modified into 3-D image, and the accumulation
of CD244 on polarizing perforin
+ cells in contact with the other
cell was confirmed from 50 sets of the 3-D image data.
HTLV-I proviral DNA load
DNA was extracted from total PBMCs of HLA-A*0201
+
HTLV-I-infected patients using QIAamp DNA Blood Mini Kit
(QIAGEN, Valencia, CA) and HTLV-1 proviral DNA load was
measured using TaqMan system as previously described [68].
Transfection with SAP small interfering RNA (siRNA)
CD8
+ T cells and CD14
+ cells were magnetically isolated from
the patient’s PBMCs by CD8
+ T cell isolation kit II and CD14
MicroBeads (both from Miltenyi), respectively, according to the
manufacturer’s instructions. The purities of CD8
+ T cells and
CD14
+ cells were confirmed as .90% cells and as approximately
95%, respectively. Purified CD8
+ T cells (3610
6 cells) were
transfected with 300 nM of control, SAP or EAT-2 siRNA using
the Human T Cell Nucleofector Kit (AMAXA, Cologne,
Germany) with the AMAXA Nucleofector II according to the
manufacturer’s instructions. Transfection efficacy for siRNA was
determined 55–70% as determined with fluorescein conjugated
control siRNA. Each transfected CD8
+ T cells were rested for
6 hours and then cocultured with an equal number of CD14
+ cells
for 24 hours. After culture, CD107a and IFN-c expression was
analyzed in CD8
+ T cells by flow cytometry.
Western blot
SAP knockdown by siRNA was determined by western blot.
After resting for 6 hours, transfected CD8
+ T cells were collected
and stored at 280uC until use. The cells were lysed in 5 mM Tris–
HCl, pH 8.0, 1% Triton X-100 and a cocktail of protease
inhibitors (Sigma). Protein concentration was determined using
Quick Start Bradford Protein Assay (BioRad, Hercules, CA). From
each protein sample, 10 mg was electrophoresed through a
NuPAGEH 12% Bis–Tris gel (Invitrogen). The gel was transferred
to a nitrocellurose membrane (Invitrogen). After blocking with 3%
BSA in TBS, the membrane was probed with anti-SAP antibodies
(Cell Signaling) and then probed with horseradish peroxidase-
conjugated IgG (Cell Signaling). The membrane was visualized by
chemiluminescence using SuperSignalH West Pico Chemilumines-
cent substrate (Thermo Scientific, Rockford, IL) and analyzed the
profile on Kodak digital science
TM 1D image analysis software
(Kodak, Rochester, NY).
Statistical analysis
Scatter plot and simple regression analysis were performed
using Prism (GraphPad software, La Jolla, CA).
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